NCT05039515 · Interventional trial
A Study to Assess the Effectiveness and Safety of 2 Dosage Regimens of Oral Fidrisertib (IPN60130) for the Treatment of Fibrodysplasia Ossificans Progressiva (FOP).
Overall registry status Terminated
Phase 2
Conditions Fibrodysplasia Ossificans Progressiva
Delaware Valley sites
- The Children's Hospital of Philadelphia · Philadelphia, PA · Philadelphia County
- The Perelman School of Medicine - The University of Pennsylvania · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory